The page is the record's research on the issuer — no analyst, no rating, no view. # NovaBridge Biosciences (NASDAQ: NBP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing NovaBridge Biosciences is listed on NASDAQ under ticker NBP, with ISIN US44975P1030 and LEI 549300L1A5T19703RR64. Its security type is recorded as non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is the Cayman Islands. Its listing status is listed, not halted. ## The disclosure read The record holds 79 filings in the twelve months from 2025-11-08 to 2026-11-08, across 53 filing days. The filings comprise 38 directors' dealings, 9 regulatory filings and 32 results. The median gap between filing days is 6.0 days, against a NASDAQ median of 6.0 days across 4359 issuers and a 2834 Pharmaceutical Preparations median of 6.0 days across 526 issuers. The latest filing is dated 2026-11-05 and is a regulatory filing, 3 days before the record date. The median latency is 5.0 days for NASDAQ and 4.0 days for the sector, and the NASDAQ median filing count is 52 against a sector median of 63.0. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section, dated 2026-11-04, carries no client categories and so the outcome cannot name its client category. ## Coverage No research houses were found on the issuer's investor-relations page, so the count is 0. ## Open research No openly published research notes were found, so the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001778016.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/NBP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/NBP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/NBP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp